(Q43642229)

25 November 2017

title

Thrombolysis in the elderly with acute myocardial infarction. The PRIAMHO study (English)

1 reference

25 November 2017

1 reference

Pabón Osuna P

1

1 reference

25 November 2017

Arós Borau F

2

1 reference

25 November 2017

San José Garagarza JM

3

1 reference

25 November 2017

Bermejo García J

4

1 reference

25 November 2017

López Bescós L

5

1 reference

25 November 2017

Montón Rodríguez AJ

6

1 reference

25 November 2017

publication date

1 November 2000

1 reference

Revista Española de Cardiología

25 November 2017

published in

1 reference

25 November 2017

volume

53

1 reference

25 November 2017

issue

11

1 reference

25 November 2017

page(s)

1443-1452

1 reference

Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Cardiovascular care of the elderly: economic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Comm

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Thrombolytic therapy for eligible elderly patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

[Variability in the management and prognosis at short- and medium-term of myocardial infarct in Spain: the PRIAMHO study. Registration Project of Hospital Acute Myocardial Infarct]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

The exclusion of the elderly and women from clinical trials in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

[Registries of morbimortality in cardiology: methods]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

[The PRIAMHO Study (The Registration Project of Hospital Acute Myocardial Infarct]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical t

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Relationship of age with eligibility for thrombolytic therapy and mortality among patients with suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Frequency of use of thrombolytic therapy in acute myocardial infarction in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years

1 reference

https://api.crossref.org/works/10.1016%2FS0300-8932%2800%2975262-6

7 January 2021

10.1016/S0300-8932(00)75262-6

Identifiers

DOI

1 reference

25 November 2017

1 reference